This can be taken 30 minutes after administration of your semaglutide therapy
doi: 10.1093/ecco-jcc/jjy004 5 AdolphTEMeyerMSchwrzlerJMayrLGrabherrFTilgH
Recent research is exploring using GLP-1 medications, such as semaglutide, to aid in weight loss during menopause
*Once-weekly semaglutide 7.2 mg in adults with obesity (STEP UP): a randomised, double-blind, phase 3 trial.* The Lancet Diabetes & Endocrinology
Like survodutide, it combines GLP-1 and glucagon receptor activity while being investigated across a variety of metabolic research applications
It is used to decrease inflammation and suppress the immune system, helping to manage conditions like asthma, arthritis, and various autoimmune disorders